# Ascend Health Intelligence — full knowledge base > Ascend Health Intelligence is a managed revenue engine. We find the right buyers with NPI-level provider intelligence and audience data, reach them with geofencing and coordinated outreach, convert them with automated follow-up, and prove the revenue with closed-loop attribution. Educational information only — not medical advice. In a crisis in the US call or text 988, or call 911. Short guide: https://ascendhealthintelligence.com/llms.txt · Feeds: https://ascendhealthintelligence.com/feeds ## Frequently asked questions Q: What is Ascend Health Intelligence? A: Ascend is a managed revenue engine, not just another software platform. We find the right buyers with NPI-level provider intelligence and audience data, reach them with geofencing and coordinated outreach, convert them with automated follow-up, and prove the revenue with closed-loop attribution. Ascend Health Intelligence is a dba of Certive Innovations Inc., a subsidiary of Certive Solutions Inc. (CTVEF), based in Scottsdale, Arizona. Q: How is Ascend different from a CRM or a data provider? A: CRMs track activity and data providers sell lists. Ascend runs the whole path, from audience intelligence through omnichannel activation, CRM follow-up and sales deployment to revenue attribution, as one accountable managed service, so clients don't assemble five vendors before demand is proven. Q: What is NPI-level targeting? A: Every U.S. healthcare provider has a National Provider Identifier (NPI). Ascend segments providers by specialty, geography and practice characteristics and combines that with first-party, search and behavioral signals to reach the specific providers most likely to use, prescribe, refer or purchase. Q: Does Ascend use geofencing? A: Yes. Ascend builds location-based audiences around practices, clinics, hospitals, imaging centers and medical conferences, alongside predictive digital audiences, and coordinates them with email, text, voice, social and PR. Q: How does Ascend lower the cost of acquisition? A: By targeting before spending, sharing a data, campaign, CRM and sales stack instead of each client building its own (about $514K a year in base payroll for a basic in-house team), coordinating every touch, and moving budget to the sources that attribution shows actually convert. Q: Who does Ascend work with today? A: Ascend's engine is live with AIM and Project Y Biotech, activating peptide-prescribing providers through AIMRx, and is launching a direct-to-consumer imaging pilot with a national diagnostic company in Arizona. It works across pharmacy and therapeutics, imaging and diagnostics, consumer health, and beyond healthcare. Q: How does Ascend handle healthcare data? A: Provider and patient data are handled through HIPAA-compliant processes from first touch to closed revenue. Q: Is Ascend raising capital? A: Ascend shares investment information only with accredited investors. Complete the accredited investor form on the Investors page to receive the investor deck. --- ## What Ascend delivers URL: https://ascendhealthintelligence.com/ ### Find the right buyer NPI, first-party, search and behavioral signals identify the providers and consumers most likely to act, before a dollar is spent. ### Reach them where they are Geofencing, digital audiences, email, text, voice, social, PR and provider events, coordinated as one campaign. ### Convert the demand Every lead is captured and routed into a defined follow-up path: education, a conversation, onboarding and ordering. ### Prove the revenue Closed-loop attribution ties each sale or provider action to its source, so budget moves to what works and the playbook is reused. --- ## Case studies URL: https://ascendhealthintelligence.com/platform ### AIM / Project Y — Provider program · live Ascend uses the engine to identify, educate, onboard and activate peptide-prescribing providers for AIM, the exclusive distributor for Project Y Biotech. - Find: NPI and audience data identify the specialty and geography segments most likely to engage. - Reach: Direct outreach plus recurring provider education: provider mixers now run monthly. - Convert: CRM follow-up routes qualified providers into AIMRx for onboarding, ordering and fulfillment. - Prove: Attribution shows which touch produced each new provider and order. ### National Diagnostic Company — Direct-to-consumer · Arizona pilot Ascend markets a national diagnostic company's mammography and cardiac imaging directly to consumers, in a 3-month Arizona pilot launching around National Mammography Day, with a path to expansion across its national network of locations. - Find: A predictive audience of validated Arizona contacts, with modeled expansion nationwide. - Reach: Ads, text, social, press and direct activation mapped across Breast Cancer Awareness Month. - Convert: Responses route straight to scheduling. - Prove: Results by channel decide expansion across the national network. --- ## Markets URL: https://ascendhealthintelligence.com/markets - $1.75B — Physician-targeted healthcare marketing (U.S.) (by 2027, up from $717M in 2022 · 19% CAGR · our beachhead) - $14.5B — Pharma & biotech contract sales outsourcing (by 2030, up from $7.1B in 2020 · 7% CAGR · expansion) - Any industry — Beyond healthcare (the same engine finds buyers for any product with a better path to market) - Pharmacy & therapeutics: Peptides, workers' comp pharmacy and men's health programs that need prescribers. - Imaging & diagnostics: Referral-volume and direct-to-consumer programs, starting with a national diagnostic company. - Consumer health: Weight-loss and wellness products that need a measurable path to buyers. - Beyond healthcare: Any company with a product that works and needs a repeatable way to reach the right buyer. Sources: ResearchAndMarkets (2022; 2021); Vision Research Reports. Third-party estimates, not projections of Ascend results. --- ## Team URL: https://ascendhealthintelligence.com/about ### Jeff Cline — President / CMO 25+ years in healthcare growth and commercialization; founder of VRTCLS and R0cketShip; prior iStemCells exit; built 1-800-MEDIGAP. ### Tom Marreel — CEO Executive oversight, governance, strategic partnerships and scaling across the business. ### Tim Hyland — CFO Finance leadership, forecasting, operating controls and capital-markets reporting. ### Michael Marreel — VP, Business Development Strategic partnerships, investor relations, business development and go-to-market coordination. --- ## Every page - [Home](https://ascendhealthintelligence.com/) - [Platform](https://ascendhealthintelligence.com/platform) - [Markets](https://ascendhealthintelligence.com/markets) - [About](https://ascendhealthintelligence.com/about) - [Brands](https://ascendhealthintelligence.com/brands) - [FAQ](https://ascendhealthintelligence.com/faq) - [Investors](https://ascendhealthintelligence.com/investors) - [Contact](https://ascendhealthintelligence.com/contact) - [Privacy](https://ascendhealthintelligence.com/privacy) - [Terms](https://ascendhealthintelligence.com/terms)